Congratulations, your medical device is a success! But don’t celebrate yet—patent litigation may be next (objectively speaking). Patents are a strategic asset in medtech, where proprietary innovation is key to improving patient outcomes, driving company growth, and securing investment. Since competitors, investors, and opportunistic non-practicing entities (NPE) are aware of the strategic advantages of patents,
GT Israel Law Blog
A Window to the Legal World for Israeli Companies
Blog Authors
Latest from GT Israel Law Blog
Building Strong Medtech Partnerships: Keys to Successful Contract Manufacturing Agreements
Medical device manufacturers face mounting pressure to deliver innovative products while reducing costs and improving margins. To meet these challenges, many original equipment manufacturers (OEMs) outsource critical operations such as manufacturing, packaging, and distribution. This shift allows OEMs to streamline resources, eliminate factories and equipment, and focus on innovation, while contract manufacturing organizations (CMOs) step…
From Innovation to IPO: A Strategic Checklist for Medtech Companies
After several years of volatility and unfavorable market dynamics, the initial public offering (IPO) market for medical technology companies is beginning to reopen meaningfully. Following the most recent IPO boom in 2020 and 2021, higher interest rates and inflation brought new IPO issuances to a near standstill from 2022 to 2024. During that period, many…
Building a Future-Proof IP Strategy for AI in Medtech
The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging analysis, drug discovery, clinical trial management, and countless other medical applications. This competitive landscape is driving substantial investment and rapid innovation, with established medtech providers,…
Why Patent Portfolios are Crucial for Life Science Innovators
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their innovations by implementing a strategic intellectual property (IP) strategy.
Patents should be the cornerstone of any life science innovator’s business strategy. Across biotechnology, pharmaceuticals, medical…
Think Before You Chat: Using AI for Legal Questions May Waive Privilege and Create Discovery Risks
With artificial intelligence tools becoming part of everyday decision-making, for some, chatbots are a first stop for help with answering questions, including questions that feel “legal” in nature. Such questions might include whether a contract clause is enforceable, how to respond to a demand letter, or what to say in an internal investigation. The AI…
Outlook 2026: Emerging Technology
As innovations continue to accelerate, the technology landscape in 2026 may reach a turning point, marking a shift from research and development (R&D) to adaptation. This year’s outlook highlights a shift towards smarter, autonomous systems that operate within the physical world. Organizations that embrace this shift may thrive, while those that lag behind may risk…
AI Patent Outlook for 2026
After years of resistance from the United States Patent and Trademark Office (USPTO) toward AI patent applications, the patent outlook for AI-related inventions in 2026 appears to be promising thanks to recent changes at the USPTO under Director John A. Squires.
On Sept. 22, 2025, the USPTO swore in Squires as its 60th director. Since…
Greenberg Traurig Launches 50th Office, Opening in Abu Dhabi
Strategic Expansion Fuels Unified Firm Growth Around the Globe
ABU DHABI, United Arab Emirates – Oct. 1, 2025 – Global law firm Greenberg Traurig has launched its 50th office. The firm has become licensed in the Abu Dhabi Global Market, an international financial centre located in Abu Dhabi. The new office continues to expand the firm’s presence…
Dr. Philip Radlanski Featured in Calcalist on How the EU AI Act Impacts Israeli Tech Companies
Greenberg Traurig’s Tel Aviv office collaborated with Dr. Philip Radlanski, Local Partner in the Intellectual Property & Technology Practice Group in GT Germany, on a recent interview with Calcalist, one of Israel’s leading business publications.
In the interview, Dr. Radlanski provides timely and practical guidance on how the European Union’s Artificial Intelligence…